Charles River Laboratories International, Inc. (NYSE: CRL) today announced the second cohort of its Cell & Gene Therapy Incubator Program (CIP). Launched in December 2024, with the inaugural cohort ...

Silicon Valley and other high tech billionaires are investing millions in start-ups dedicated to creating genetically ...

Whether you turn red when drinking alcohol, dislike certain smells, or metabolize drugs differently from others, the ...

More than a decade after the first Neanderthal genome was sequenced, scientists are still working to understand how ...

In his proposal to NSF, Luo coined this rich-get-richer effect “annotation inequality.” One problem of annotation inequality ...

A recent study highlights how DNA microarray technology enables high-throughput gene analysis, supporting variation detection, expression ...

The rollout of a type of genetic technology called a gene drive for tackling malaria could be edging closer after a lab study ...

Dyadic International, Inc. ( DYAI) IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 9:30 AM EST Good day, and welcome to the iAcessAlpha Virtual Best Ideas winter ...

MOST STORIES about gene-edited children begin with He Jiankui, a rogue Chinese scientist who, in 2018, announced that he had created the world’s first such babies in secret. His reckless and illegal ...

A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier ...